Review
[Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin]
[Article in
Polish]
Affiliations
- PMID: 15690716
Item in Clipboard
Review
[Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin]
[Article in
Polish]
Pol Merkur Lekarski.
2004 Oct.
Abstract
Due to appearance in the world scientific literature of reports on occurrence of pure red cell aplasia (PRCA) as an adverse effect of treatment with recombinant human erythropoietin administered for anemia correction in the course of chronic renal failure, the paper presents rules of diagnosis and treatment of this complication. PRCA is more frequently observed during subcutaneous administration of erythropoietin a than erythropoietin beta. According to currently available analysis, prophylaxis of PRCA may include changing of the route of erythropoietin alpha administration from subcutaneous to intravenous one.
Similar articles
-
Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.Curr Med Res Opin. 2004 Jan;20(1):83-6. doi: 10.1185/030079903125002702. Curr Med Res Opin. 2004. PMID: 14741076 Review.
-
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.Best Pract Res Clin Haematol. 2005;18(3):481-9. doi: 10.1016/j.beha.2005.01.017. Best Pract Res Clin Haematol. 2005. PMID: 15792923 Review.
-
[Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].Cas Lek Cesk. 2003;142(12):741-5. Cas Lek Cesk. 2003. PMID: 14746223 Review. Czech.
-
Pure red-cell aplasia and epoetin therapy.N Engl J Med. 2004 Sep 30;351(14):1403-8. doi: 10.1056/NEJMoa040528. N Engl J Med. 2004. PMID: 15459301
-
Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?Nephrol Dial Transplant. 2005 Sep;20 Suppl 8:viii18-21. doi: 10.1093/ndt/gfh1112. Nephrol Dial Transplant. 2005. PMID: 16079325 Review.